Source https://www.fightaging.org/archives/2022/03/many-mediocre-cancer-therapies-become-much-better-when-more-targeted-to-cancerous-tissues/
One of the important areas of cancer research and development that appears to receive a great deal of attention and funding, but in practice seems slow to make it from the laboratory to the clinic, is the targeting of therapeutics to cancerous cells. Reductio ad absurdum, near any of dozens of existing chemotherapeutics would do the job of completely clearing tumors, with minimal to no side-effects, if one could only find a way to delivery tiny amounts of the therapeutic to every cancer cell while avoiding every healthy cell. The inability to target treatments this effectively is exactly why cancer remains such a problem. Killing cells is easy. Killing only the desired cells is hard.
Today’s research materials provide an example of this principle. Tumors compromise the <a href="https://en.wikipedia.org/…
Source https://www.fightaging.org/archives/2022/03/many-mediocre-cancer-therapies-become-much-better-when-more-targeted-to-cancerous-tissues/
One of the important areas of cancer research and development that appears to receive a great deal of attention and funding, but in practice seems slow to make it from the laboratory to the clinic, is the targeting of therapeutics to cancerous cells. Reductio ad absurdum, near any of dozens of existing chemotherapeutics would do the job of completely clearing tumors, with minimal to no side-effects, if one could only find a way to delivery tiny amounts of the therapeutic to every cancer cell while avoiding every healthy cell. The inability to target treatments this effectively is exactly why cancer remains such a problem. Killing cells is easy. Killing only the desired cells is hard.
Today’s research materials provide an example of this principle. Tumors compromise the <a href="https://en.wikipedia.org/…
What Do You Think?
comments